The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Share News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: BlackRock Smaller net asset value down; Insig hopeful

Thu, 03rd Nov 2022 14:26

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Blackrock Smaller Companies Trust PLC - FTSE250-listed investment trust focused on smaller UK quoted companies - Net asset value per share at the end of the half-year that ended August 31 falls 18% to 1,536.94 pence from 1,878.11p at February 28. Declares 14.50p per share interim dividend, up 12% from 13.00p a year ago. "We face a period of further interest increases and a number of unknowns regarding changes in fiscal policy in general and taxation in particular," Blackrock Smaller Chair Ronald Gould says on Thursday, the day the Bank of England hiked the UK bank rate to 3.00% from 2.25%. Gould notes other global issues such energy prices due to the war in Ukraine, and lockdowns in China.

----------

Brandshield Systems PLC - London-based cybersecurity solutions provider - Reports continued strong business momentum across the third quarter of 2022. Adds it secured new contracts in the US, which it calls a "key territory". Number of clients increases 12% to 172 at the end of the third quarter from 153 at the end of the first half of 2022. Looking ahead, Chief Executive Officer Yoav Keren says: "We are developing an enviable portfolio of clients to continue our mission of safeguarding brands from various online threats which are heavily disrupting the daily operations of businesses globally, and we look forward to providing shareholders with further updates on significant business activities."

----------

Insig AI PLC - London-based data science and machine learning - Anticipates to become cash flow positive from the second quarter of 2023 due to cost cutting action. Cost reduction included lowering the number of Insig employees. "With recent uncertainty in the asset management and funding markets having increased significantly, we must adapt and accelerate the timing of profitability. Whilst it would have been ideal to have continued to expand our coverage into more smaller companies, the return on this investment would extend beyond our appetite," says CEO Colm McVeigh.

----------

Libertine Holdings PLC - Sheffield, England-based developer of technology for power generation from renewable fuels - Expects commercial revenue of GBP600,000 in the first half that ended September 30, up from GBP100,000 a year ago. Since March, has completed performance validation prototype design and manufacture for the combustion testing of Mahle Powertrain, which will take place in third quarter of financial year 2023. Notes increasing engagement with potential original equipment manufacture clients and manufacturing partners in UK, US, Europe and India.

----------

Yourgene Health PLC - Manchester-based molecular diagnostics - Core revenue in the first half-year that ended September 30 excluding Covid activities grows 14% to GBP8.0 million from GBP7.0 million a year ago. Revenue falls 45% to GBP9.6 million from GBP17.5 million. The fall in revenue reflects the transition away from Covid services, Yourgene explains. It cautions on upcoming margin erosion due to inflationary and economic pressures in the UK, as well as currency fluctuations. The firm expects margins to stay below the 60% level that is previously forecast, for the remainder of the financial year that ends March 31. However, Yourgene remains on track to cut operating costs by GBP5 million. "Whilst margins have been impacted by the current external environment, we are continuing to reshape the business and are evaluating the best ways to manage costs without constraining future growth where possible. The year-to-date performance informs the board's confidence in the business remaining on track to deliver full-year revenues in line with expectations and to prioritise market penetration over near-term earnings before interest, tax, depreciation and amortisation delivery," says CEO Lyn Rees.

----------

By Tom Budszus; tombudszus@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
8 Sep 2023 11:58

Novacyt completes buy of molecular diagnostics firm Yourgene Health

(Alliance News) - Yourgene Health PLC on Friday announced that its takeover by Novacyt SA, a biotechnology group focused on clinical diagnostics, is complete.

Read more
7 Sep 2023 20:27

TRADING UPDATES: Tintra receives bid approach; NCC trading in line

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
1 Sep 2023 21:59

Yourgene, Pathfinder, Spectral MD and Finncap to be deleted on AIM

(Alliance News) - FTSE Russell on Friday announced a number of deletion changes in the FTSE UK Index series.

Read more
17 Aug 2023 19:46

IN BRIEF: Novacyt takeover of Yourgene Health closer to completion

Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Reports court-sanctioned scheme of arrangement to facilitate takeover by Novacyt SA has been approved by shareholders at a court and general meeting. Around 99% of shareholders who voted were in favour of the scheme. Takeover now requires the scheme of arrangement to be court sanctioned. These timings will be provided in due course.

Read more
10 Aug 2023 15:46

UK shareholder meetings calendar - next 7 days

Friday 11 August 
Crushmetric Group LtdAGM
SIMEC Atlantis Energy LtdAGM
TwentyFour Select Monthly Income Fund LtdAGM
Monday 14 August 
Ethernity Networks LtdAGM
Nanoco Group PLCGM re change in the control of the company
Tuesday 15 August 
Castings PLCAGM
Momentum Multi-Asset Value Trust PLCGM re reconstruction and voluntary winding-up
Primorus Investments PLCAGM
WH Ireland Group PLCGM re dealings in the new ordinary shares
Wednesday 16 August 
Cadence Minerals PLCAGM
Calnex Solutions PLCAGM
NextEnergy Solar Fund LtdAGM
NFT Investments PLCAGM
StreaksAI PLCAGM
VSA Capital Group PLCAGM
Thursday 17 August 
Harvest Minerals LtdAGM
Quantum Exponential Group PLCAGM
Windward LtdAGM
Yourgene Health PLCGM and court meeting re takeover by Novacyt
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Jul 2023 16:30

TRADING UPDATES: Ithaca encouraged by K2; Safestyle profit warning

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
26 Jul 2023 12:44

IN BRIEF: Yourgene Health inks five-year, Illumina contract extension

Yourgene Health PLC - Manchester, England-based molecular diagnostics group - Signs five-year contract extension with Illumina Inc. The contract is a restated licence and supply agreement for Yourgene's sequencing based NIPT in vitro diagnostic products, which will now run until September 2028. Says the license allows it to continue its product development roadmaps, as it looks to further move into "key international markets, such as the Americas, UK, Europe and Australia.

Read more
3 Jul 2023 12:05

LONDON MARKET MIDDAY: Miners and oil majors lead FTSE 100 march

(Alliance News) - European equities went into Monday afternoon on the up, with the FTSE 100 outperforming as it was supported by its natural resources sector and oil majors.

Read more
3 Jul 2023 10:48

AIM WINNERS & LOSERS: Yourgene surges on takeover by Novacyt

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
3 Jul 2023 10:13

Yourgene Health agrees to GBP17 million acquisition offer from Novacyt

(Alliance News) - Yourgene Health PLC on Monday said it has agreed to a cash takeover offer from Novacyt SA that values Yourgene about GBP17 million.

Read more
3 Jul 2023 09:07

LONDON MARKET OPEN: Stocks start second half in green amid PMIs

(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York,

Read more
3 Jul 2023 09:07

Novacyt to buy Yourgene Health in £16.7m deal

(Sharecast News) - Yourgene Health surged on Monday after it agreed to be bought by Novacyt in a £16.7m deal.

Read more
13 Jun 2023 10:08

Yourgene Health shares rise on sale of Taiwan subsidiary

(Alliance News) - Yourgene Health PLC on Tuesday said it will sell its subsidiary Yourgene Health Taiwan Co Ltd to INEX Innovate Pte Ltd for up to USD4 million

Read more
22 May 2023 14:26

Yourgene to process tests at lab as part of MyHealthChecked Boots deal

(Alliance News) - Yourgene Health PLC on Monday said that is due to process diagnostic tests at its laboratory in Manchester, as part of a deal signed by its partner, MyHealthChecked PLC, with Boots UK Ltd.

Read more
27 Apr 2023 17:35

TRADING UPDATES: Yourgene Health sees revenue above market forecasts

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.